Searched for
MANKIND AND BDR PHARMA
Stock market update: Nifty Pharma index advances 1.4%The Nifty Pharma index closed 1.4 per cent up at 21738.95.- Stock market update: Nifty Pharma index 0.13%The Nifty Pharma index closed 0.13 per cent at 22434.75.
- PE firms queue up for Novartis' Indian armThe PE firms are up against Dr Reddy's, which has an alliance with Novartis for marketing some of its off-patent products and is also expec...
- Stock market update: Nifty Pharma index advances 0.12%The Nifty Pharma index closed 0.12 per cent up at 23457.65.
- Stock market update: Nifty Pharma index advances 0.77%The Nifty Pharma index closed 0.77 per cent up at 22729.0.
- Stock market update: Nifty Pharma index falls 0.14%The Nifty Pharma index closed 0.14 per cent down at 22546.1.
- Stock market update: Nifty Pharma index advances 2.36%The Nifty Pharma index closed 2.36 per cent up at 21603.1.
- Stock market update: Nifty Pharma index advances 0.06%The Nifty Pharma index closed 0.06 per cent up at 19532.3.
- Stock market update: Nifty Pharma index falls 0.92%The Nifty Pharma index closed 0.92 per cent down at 19644.5.
- Multiples Alternate buys into BDR Pharma, invests Rs 750 crET was the first to report in July last year that global and domestic PE funds were in initial discussions to purchase a minority stake in ...
- Mankind, BDR Pharma join hands to launch anti COVID-19 pill MolulifeMankind Pharma on Wednesday said it has joined hands with BDR Pharmaceuticals to launch oral anti-COVID-19 pill Molulife (Molnupiravir) in ...
- Mankind Pharma inks distribution pact with BDR Pharmaceuticals for COVID drugUnder the alliance, BDR Pharma will be manufacturing and marketing the product under a royalty free, limited and non-exclusive voluntary li...
- Pharma companies to vendors: Be GST-ready to avoid delay in paymentsMany manufactures who undertake production for Indian as well as multinational drug majors are rushing to put GST infrastructure in place.
Load More
